2 Biotech Firms To Pay $10M For Mischarging Fed Grants

By Gina Kim (December 22, 2022, 5:06 PM EST) -- Two biotech companies, iSense LLC and Specific Diagnostics, and their owner have agreed to pay more than $10 million to the U.S. to resolve False Claims Act allegations that they improperly billed for costs to federal grants, Northern California federal prosecutors announced Wednesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!